PepGen Inc. Common Stock PEPG · Stock Open PepGen Inc. Common Stock in new tab
PepGen Inc. Common Stock Analysis (PEPG)
Is PepGen Inc. Common Stock a good investment? PepGen Inc. Common Stock (PEPG) is currently trading at 1.88 USD. Market analysts have a consensus price target of 10.25 USD. This suggests a potential upside from current levels.
Earnings Schedule: PepGen Inc. Common Stock is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is -1.23.
Investor FAQ
Does PepGen Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is PepGen Inc. Common Stock?
PepGen Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -1.50.
Company Profile
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Community Discussion